The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells

Immunity

Volumn 17, Issue 4, 2002, Pages 437-449

  Lacorazza, H Daniel ^a   Miyazaki, Yasushi ^a   Di Cristofano, Antonio ^a   Deblasio, Anthony ^a   Hedvat, Cyrus ^a   Zhang, Jin ^a   Cordon Cardo, Carlos ^a   Mao, Shifeng ^a   Pandolfi, Pier Paolo ^a   Nimer, Stephen D ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; PERFORIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR MEF; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL MATURATION; CELL SECRETION; CELLULAR IMMUNITY; CHROMATIN; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; GENE; GENE EXPRESSION; GENE TARGETING; GENETIC REGULATION; GENETIC TRANSCRIPTION; HOMOLOGOUS RECOMBINATION; IMMUNOPRECIPITATION; LYMPHOPOIESIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; T LYMPHOCYTE; TUMOR CELL;

EID: 18644379642     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(02)00422-3     Document Type: Article

References (57)

1. Arase H., Arase N., Nakagawa K., Good R.A., Onoe K. NK1.1+ CD4+ CD8- thymocytes with specific lymphokine secretion. Eur. J. Immunol. 23:1993;307-310.
2. Badovinac V.P., Tvinnereim A.R., Harty J.T. Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-γ Science. 290:2000;1354-1358.
3. Barton K., Muthusamy N., Fischer C., Ting C.N., Walunas T.L., Lanier L.L., Leiden J.M. The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity. 9:1998;555-563.
4. Bendelac A. Mouse NK1+ T cells. Curr. Opin. Immunol. 7:1995;367-374.
5. Bendelac A., Rivera M.N., Park S.H., Roark J.H. Mouse CD1-specific NK1 T cells. development, specificity, and function Annu. Rev. Immunol. 15:1997;535-562.
6. Benlagha K., Kyin T., Beavis A., Teyton L., Bendelac A. A thymic precursor to the NK T cell lineage. Science. 296:2002;553-555.
7. Bories J.C., Willerford D.M., Grevin D., Davidson L., Camus A., Martin P., Stehelin D., Alt F.W. Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature. 377:1995;635-638.
8. Ceredig R., Lowenthal J.W., Nabholz M., MacDonald H.R. Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells. Nature. 314:1985;98-100.
9. Cooper M.A., Fehniger T.A., Caligiuri M.A. The biology of human natural killer-cell subsets. Trends Immunol. 22:2001;633-640.
10. Dennert G., Hyman R., Lesley J., Trowbridge I.S. Effects of cytotoxic monoclonal antibody specific for T200 glycoprotein on functional lymphoid cell populations. Cell. Immunol. 53:1980;350-364.
11. Fadeel B., Orrenius S., Henter J.I. Familial hemophagocytic lymphohistiocytosis. too little cell death can seriously damage your health Leuk. Lymphoma. 42:2001;13-20.
12. Fehling H.J., von Boehmer H. Early αβ T cell development in the thymus of normal and genetically altered mice. Curr. Opin. Immunol. 9:1997;263-275.
13. Garrett-Sinha L.A., Dahl R., Rao S., Barton K.P., Simon M.C. PU.1 exhibits partial functional redundancy with Spi-B, but not with Ets-1 or Elf-1. Blood. 97:2001;2908-2912.
14. Godfrey D.I., Zlotnik A. Control points in early T-cell development. Immunol. Today. 14:1993;547-553.
15. Gottschalk L.R., Giannola D.M., Emerson S.G. Molecular regulation of the human IL-3 gene. inducible T cell- restricted expression requires intact AP-1 and Elf-1 nuclear protein binding sites J. Exp. Med. 178:1993;1681-1692.
16. Hart A., Melet F., Grossfeld P., Chien K., Jones C., Tunnacliffe A., Favier R., Bernstein A. Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity. 13:2000;167-177.
17. Iwama A., Zhang P., Darlington G.J., McKercher S.R., Maki R., Tenen D.G. Use of RDA analysis of knockout mice to identify myeloid genes regulated in vivo by PU.1 and C/EBPα Nucleic Acids Res. 26:1998;3034-3043.
18. Kagi D., Odermatt B., Mak T.W. Homeostatic regulation of CD8+ T cells by perforin. Eur. J. Immunol. 29:1999;3262-3272.
19. Kai H., Hisatsune A., Chihara T., Uto A., Kokusho A., Miyata T., Basbaum C. Myeloid ELF-1-like factor up-regulates lysozyme transcription in epithelial cells. J. Biol. Chem. 274:1999;20098-20102.
20. Kanakaraj P., Migone T.S., Nardelli B., Ullrich S., Li Y., Olsen H.S., Salcedo T.W., Kaufman T., Cochrane E., Gan Y.et al. BLyS binds to B cells with high affinity and induces activation of the transcription factors NF-κB AND ELF-1. Cytokine. 13:2001;25-31.
21. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., Ueno H., Nakagawa R., Sato H., Kondo E.et al. CD1d-restricted and TCR-mediated activation of vα 14 NKT cells by glycosylceramides. Science. 278:1997;1626-1629.
22. Koizumi H., Horta M.F., Youn B.S., Fu K.C., Swon B.S., Young J.D., Liu C.C. Identification of a killer cell-specific regulatory element of the mouse perforin gene. an Ets-binding site-homologous motif that interacts with Ets-related proteins Mol. Cell. Biol. 13:1993;6690-6701.
23. Koseki H., Asano H., Inaba T., Miyashita N., Moriwaki K., Lindahl K.F., Mizutani Y., Imai K., Taniguchi M. Dominant expression of a distinctive V14+ T-cell antigen receptor α chain in mice. Proc. Natl. Acad. Sci. USA. 88:1991;7518-7522.
24. Lantz O., Bendelac A. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans. J. Exp. Med. 180:1994;1097-1106.
25. Leiden J.M., Wang C.Y., Petryniak B., Markovitz D.M., Nabel G.J., Thompson C.B. A novel Ets-related transcription factor, Elf-1, binds to human immunodeficiency virus type 2 regulatory elements that are required for inducible trans activation in T cells. J. Virol. 66:1992;5890-5897.
26. Lichtenheld M.G., Podack E.R. Structure and function of the murine perforin promoter and upstream region. Reciprocal gene activation or silencing in perforin positive and negative cells. J. Immunol. 149:1992;2619-2626.
27. Liu C.C., Walsh C.M., Young J.D. Perforin. structure and function Immunol. Today. 16:1995;194-201.
28. Mao S., Frank R.C., Zhang J., Miyazaki Y., Nimer S.D. Functional and physical interactions between AML1 proteins and an ETS protein, MEF. implications for the pathogenesis of t(8;21)-positive leukemias Mol. Cell. Biol. 19:1999;3635-3644.
29. McKercher S.R., Torbett B.E., Anderson K.L., Henkel G.W., Vestal D.J., Baribault H., Klemsz M., Feeney A.J., Wu G.E., Paige C.J., Maki R.A. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15:1996;5647-5658.
30. Miyazaki Y., Sun X., Uchida H., Zhang J., Nimer S. MEF, a novel transcription factor with an Elf-1 like DNA binding domain but distinct transcriptional activating properties. Oncogene. 13:1996;1721-1729.
31. Miyazaki Y., Boccuni P., Mao S., Zhang J., Erdjument-Bromage H., Tempst P., Kiyokawa H., Nimer S.D. Cyclin A-dependent phosphorylation of the ETS-related protein, MEF, restricts its activity to the G1 phase of the cell cycle. J. Biol. Chem. 276:2001;40528-40536.
32. Moore T.A., Bennett M., Kumar V. Murine natural killer cell differentiation. past, present, and future Immunol. Res. 15:1996;151-162.
33. Muthusamy N., Barton K., Leiden J.M. Defective activation and survival of T cells lacking the Ets-1 transcription factor. Nature. 377:1995;639-642.
34. Nikolic-Zugic J. Phenotypic and functional stages in the intrathymic development of αβ T cells. Immunol. Today. 12:1991;65-70.
35. Nimer S., Zhang J., Avraham H., Miyazaki Y. Transcriptional regulation of interleukin-3 expression in megakaryocytes. Blood. 88:1996;66-74.
36. Papas T.S., Bhat N.K., Spyropoulos D.D., Mjaatvedt A.E., Vournakis J., Seth A., Watson D.K. Functional relationships among ETS gene family members. Leukemia Suppl. 11:1997;557-566.
37. + CD1d-dependent precursor stage. J. Exp. Med. 195:2002;835-844.
38. Podack E.R., Hengartner H., Lichtenheld M.G. A central role of perforin in cytolysis? Annu. Rev. Immunol. 9:1991;129-157.
39. Raulet D.H. Expression and function of interleukin-2 receptors on immature thymocytes. Nature. 314:1985;101-103.
40. Sanchez M.J., Muench M.O., Roncarolo M.G., Lanier L.L., Phillips J.H. Identification of a common T/natural killer cell progenitor in human fetal thymus. J. Exp. Med. 180:1994;569-576.
41. Scott E.W., Simon M.C., Anastasi J., Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science. 265:1994;1573-1577. a.
42. Scott G.K., Daniel J.C., Xiong X., Maki R.A., Kabat D., Benz C.C. Binding of an ETS-related protein within the DNase I hypersensitive site of the HER2/neu promoter in human breast cancer cells. J. Biol. Chem. 269:1994;19848-19858. b.
43. Sharrocks A.D., Brown A.L., Ling Y., Yates P.R. The ETS-domain transcription factor family. Int. J. Biochem. Cell Biol. 29:1997;1371-1387.
44. Shortman K., Wu L. Early T lymphocyte progenitors. Annu. Rev. Immunol. 14:1996;29-47.
45. Spain L.M., Guerriero A., Kunjibettu S., Scott E.W. T cell development in PU.1-deficient mice. J. Immunol. 163:1999;2681-2687.
46. Stepp S.E., Dufourcq-Lagelouse R., Le Deist F., Bhawan S., Certain S., Mathew P.A., Henter J.I., Bennett M., Fischer A., de Saint Basile G., Kumar V. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 286:1999;1957-1959.
47. Stepp S.E., Mathew P.A., Bennett M., de Saint Basile G., Kumar V. Perforin. more than just an effector molecule Immunol. Today. 21:2000;254-256.
48. Street S.E., Cretney E., Smyth M.J. Perforin and interferon-γ activities independently control tumor initiation, growth, and metastasis. Blood. 97:2001;192-197.
49. Su G.H., Chen H.M., Muthusamy N., Garrett-Sinha L.A., Baunoch D., Tenen D.G., Simon M.C. Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B. EMBO J. 16:1997;7118-7129.
50. Vicari A.P., Zlotnik A. Mouse NK1.1+ T cells. a new family of T cells Immunol. Today. 17:1996;71-76.
51. Walunas T.L., Wang B., Wang C.R., Leiden J.M. Cutting edge. the Ets1 transcription factor is required for the development of NK T cells in mice J. Immunol. 164:2000;2857-2860.
52. Wang C.Y., Petryniak B., Thompson C.B., Kaelin W.G., Leiden J.M. Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein. Science. 260:1993;1330-1335.
53. Wang L.C., Kuo F., Fujiwara Y., Gilliland D.G., Golub T.R., Orkin S.H. Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL. EMBO J. 16:1997;4374-4383.
54. Wilson S.B., Byrne M.C. Gene expression in NKT cells. defining a functionally distinct CD1d-restricted T cell subset Curr. Opin. Immunol. 13:2001;555-561.
55. Yu C.R., Ortaldo J.R., Curiel R.E., Young H.A., Anderson S.K., Gosselin P. Role of a STAT binding site in the regulation of the human perforin promoter. J. Immunol. 162:1999;2785-2790.
56. Zhang Y., Lichtenheld M.G. Non-killer cell-specific transcription factors silence the perforin promoter. J. Immunol. 158:1997;1734-1741.
57. Zuniga-Pflucker J.C., Lenardo M.J. Regulation of thymocyte development from immature progenitors. Curr. Opin. Immunol. 8:1996;215-224.